Search results

519 results

View results as:
Number of results to display per page
Book
1 online resource. Digital: text file; PDF.
Book
1 online resource (x, 350 pages).
Book
xii, 270 pages : illustrations (some color) ; 25 cm
  • States of matter related to pharmacuetical formulations / Beverly J. Sandmann, Ann Newman, and Gregory T. Knipp
  • Physical properties of solutions / Beverly Sandmann, Antoine Al-Achi, Robert Greenwood
  • Ionic equilibrium and buffers / Beverly Sandmann, Alekha K. Dash, Antoine Al-Achi, Robert Greenwood
  • Solubility, dissolution, and partitioning/ Beverly J. Sandmann and Mansoor M. Amiji
  • Mass transport / Mansoor M. Amiji
  • Complexation and protein binding / Mansoor M. Amiji
  • Dispersed systems / W. Cary Mobley
  • Interfacial phenomena / Maria Polikandritou Lambros and SHihong Li Nocolaou
  • Rheology / Maria Polikandritou Lambros
  • Chemical kinetics of pharmaceuticals / Thomas J. Cook.
  • States of matter related to pharmacuetical formulations / Beverly J. Sandmann, Ann Newman, and Gregory T. Knipp
  • Physical properties of solutions / Beverly Sandmann, Antoine Al-Achi, Robert Greenwood
  • Ionic equilibrium and buffers / Beverly Sandmann, Alekha K. Dash, Antoine Al-Achi, Robert Greenwood
  • Solubility, dissolution, and partitioning/ Beverly J. Sandmann and Mansoor M. Amiji
  • Mass transport / Mansoor M. Amiji
  • Complexation and protein binding / Mansoor M. Amiji
  • Dispersed systems / W. Cary Mobley
  • Interfacial phenomena / Maria Polikandritou Lambros and SHihong Li Nocolaou
  • Rheology / Maria Polikandritou Lambros
  • Chemical kinetics of pharmaceuticals / Thomas J. Cook.
Chemistry & ChemEng Library (Swain)
Status of items at Chemistry & ChemEng Library (Swain)
Chemistry & ChemEng Library (Swain) Status
Stacks
RS403 .A676 2014 Unknown
Book
1 online resource (vii, 200 pages) : illustrations (some color).
  • Next Generation Sequencing: Chemistry, Technology and Applications, by P. Hui
  • Application of Next Generation Sequencing to Molecular Diagnosis of Inherited Diseases, by W. Zhang, H. Cui, L.-J.C. Wong
  • Clinical Applications of the Latest Molecular Diagnostics in Noninvasive Prenatal Diagnosis, by K.C.A. Chan
  • The Role of Protein Structural Analysis in the Next Generation Sequencing Era, by W.W. Yue, D.S. Froese, P.E. Brennan
  • Emerging Applications of Single-Cell Diagnostics, by M. Shirai, T. Taniguchi, H. Kambara
  • Mass Spectrometry in High-Throughput Clinical Biomarker Assays: Multiple Reaction Monitoring, by C.E. Parker, D. Domanski, A.J. Percy, A.G. Chambers, A.G. Camenzind, D.S. Smith, C.H. Borchers
  • Advances in MALDI Mass Spectrometry in Clinical Diagnostic Applications, by E.W.Y. Ng, M.Y.M. Wong, T.C.W. Poon
  • Application of Mass Spectrometry in Newborn Screening: About Both Small Molecular Diseases and Lysosomal Storage Diseases, by W.-L. Hwu, Y.-H. Chien, N.-C. Lee, S.-F. Wang, S.-C. Chiang, L.-W. Hsu.
  • Next Generation Sequencing: Chemistry, Technology and Applications, by P. Hui
  • Application of Next Generation Sequencing to Molecular Diagnosis of Inherited Diseases, by W. Zhang, H. Cui, L.-J.C. Wong
  • Clinical Applications of the Latest Molecular Diagnostics in Noninvasive Prenatal Diagnosis, by K.C.A. Chan
  • The Role of Protein Structural Analysis in the Next Generation Sequencing Era, by W.W. Yue, D.S. Froese, P.E. Brennan
  • Emerging Applications of Single-Cell Diagnostics, by M. Shirai, T. Taniguchi, H. Kambara
  • Mass Spectrometry in High-Throughput Clinical Biomarker Assays: Multiple Reaction Monitoring, by C.E. Parker, D. Domanski, A.J. Percy, A.G. Chambers, A.G. Camenzind, D.S. Smith, C.H. Borchers
  • Advances in MALDI Mass Spectrometry in Clinical Diagnostic Applications, by E.W.Y. Ng, M.Y.M. Wong, T.C.W. Poon
  • Application of Mass Spectrometry in Newborn Screening: About Both Small Molecular Diseases and Lysosomal Storage Diseases, by W.-L. Hwu, Y.-H. Chien, N.-C. Lee, S.-F. Wang, S.-C. Chiang, L.-W. Hsu.

5. Chemistry of drugs [2014]

Book
x, 260 p. : ill. ; 24 cm.
Chemistry & ChemEng Library (Swain)
Status of items at Chemistry & ChemEng Library (Swain)
Chemistry & ChemEng Library (Swain) Status
Stacks
RS403 .B27 2014 Unknown
Book
1 online resource (xv, 415 pages)
Book
xiii, 146 p. : ill. ; 24 cm
Chemistry & ChemEng Library (Swain)
Status of items at Chemistry & ChemEng Library (Swain)
Chemistry & ChemEng Library (Swain) Status
Stacks
RS407 .D53 2014 Unknown
Book
xii, 385 p. : ill.
  • ch. 1. Generic drug product development and therapeutic equivalence / Leon Shargel and Isadore Kanfer
  • ch. 2. Active pharmaceutical ingredients / Edward M. Cohen and Steven Sutherland
  • ch. 3. Analytical methods development and methods validation for oral solid dosage forms / Quanyin Gao and Dilip R. Sanvordeker
  • ch. 4. Experimental formulation development / Isadore Kanfer ... [et al.]
  • ch. 5. Scale-up, technology transfer, and process performance qualification / Salah U. Ahmed ... [et al.]
  • ch. 6. Drug stability / Pranab K. Bhattacharyya
  • ch. 7. Quality control and quality assurance / Loren Gelber
  • ch. 8. Drug product performance : in vitro / Pradeep M. Sathe, John Duan, and Lawrence X. Yu
  • ch. 9. ANDA regulatory approval process / Timothy W. Ames and Aaron Sigler
  • ch. 10. Bioequivalence and drug product assessment : in vivo / Barbara M. Davit and Dale P. Conner
  • ch. 11. Statistical considerations for establishing bioequivalence / Charles Bon and Sanford Bolton
  • ch. 12. Outsourcing bioavailability and bioequivalence studies to contract research organizations / Patrick K. Noonan
  • ch. 13. Postapproval changes and postmarketing reporting of adverse drug experiences / Lorien Armour and Leon Shargel
  • ch. 14. The United States pharmacopeia/national formulary : its history, organization, and role in harmonization / William Brown and Margareth R.C. Marques
  • ch. 15. Legal and legislative hurdles to generic drug development, approval, and marketing / Arthur Y. Tsien.
"This book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulations, pharmaceutical ingredients, conventional and modified-release products, and bioequivalence. It considers key elements in the formulation of generic drug products including the availability of raw materials and chemical purity. It contains new chapters on experimental formulation development, and the relationship between the FDA and the United States Pharmacopeia"--Provided by publisher.
  • ch. 1. Generic drug product development and therapeutic equivalence / Leon Shargel and Isadore Kanfer
  • ch. 2. Active pharmaceutical ingredients / Edward M. Cohen and Steven Sutherland
  • ch. 3. Analytical methods development and methods validation for oral solid dosage forms / Quanyin Gao and Dilip R. Sanvordeker
  • ch. 4. Experimental formulation development / Isadore Kanfer ... [et al.]
  • ch. 5. Scale-up, technology transfer, and process performance qualification / Salah U. Ahmed ... [et al.]
  • ch. 6. Drug stability / Pranab K. Bhattacharyya
  • ch. 7. Quality control and quality assurance / Loren Gelber
  • ch. 8. Drug product performance : in vitro / Pradeep M. Sathe, John Duan, and Lawrence X. Yu
  • ch. 9. ANDA regulatory approval process / Timothy W. Ames and Aaron Sigler
  • ch. 10. Bioequivalence and drug product assessment : in vivo / Barbara M. Davit and Dale P. Conner
  • ch. 11. Statistical considerations for establishing bioequivalence / Charles Bon and Sanford Bolton
  • ch. 12. Outsourcing bioavailability and bioequivalence studies to contract research organizations / Patrick K. Noonan
  • ch. 13. Postapproval changes and postmarketing reporting of adverse drug experiences / Lorien Armour and Leon Shargel
  • ch. 14. The United States pharmacopeia/national formulary : its history, organization, and role in harmonization / William Brown and Margareth R.C. Marques
  • ch. 15. Legal and legislative hurdles to generic drug development, approval, and marketing / Arthur Y. Tsien.
"This book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulations, pharmaceutical ingredients, conventional and modified-release products, and bioequivalence. It considers key elements in the formulation of generic drug products including the availability of raw materials and chemical purity. It contains new chapters on experimental formulation development, and the relationship between the FDA and the United States Pharmacopeia"--Provided by publisher.
Book
xiv, 243 pages : illustrations (some color) ; 25 cm
  • Seduced by drug discovery
  • The small molecules of life
  • Proteins : molecular wonders in three dimensions
  • Proteins perform multiple functions : enzymes, receptors, ion channels
  • Drug discovery and development : the road from an idea to promoting human health
  • Finasteride : the Gary and Jerry show
  • Basic research, snake venoms, and ACE inhibitors : Ondetti, Cushman, and Patchett
  • Statins : protection against heart attacks and strokes
  • The perils of primaxin
  • Avermectins : molecules of life battle parasites
  • Fludalanine : nice try but no hallelujah
  • Diabetes breakthrough : Januvia and Janumet.
  • Seduced by drug discovery
  • The small molecules of life
  • Proteins : molecular wonders in three dimensions
  • Proteins perform multiple functions : enzymes, receptors, ion channels
  • Drug discovery and development : the road from an idea to promoting human health
  • Finasteride : the Gary and Jerry show
  • Basic research, snake venoms, and ACE inhibitors : Ondetti, Cushman, and Patchett
  • Statins : protection against heart attacks and strokes
  • The perils of primaxin
  • Avermectins : molecules of life battle parasites
  • Fludalanine : nice try but no hallelujah
  • Diabetes breakthrough : Januvia and Janumet.
SAL1&2 (on-campus shelving)
Status of items at SAL1&2 (on-campus shelving)
SAL1&2 (on-campus shelving) Status
Stacks Request
RM301.25 .C67 2014 Unknown
Book
1 online resource (ix, 326 pages) : illustrations (some color).
  • 1 Hydrophilic Matrix Dosage Forms: Definitions, General Attributes and the Evolution of Clinical Utilization
  • 2 Design and Evaluation of Hydroxypropyl Methylcellulose Matrix Tablets for Oral Controlled Release: a Historical Perspective
  • 3 An Industrial Perspective on Hydrophilic Matrix Tablets based on Hyproxypropyl Methylcellulose (Hypromellose)
  • 4 Natural Polysaccharides in Hydrophilic Matrices
  • 5 Applications of Polyethylene Oxide (POLYOX) in Hydrophilic Matrices
  • 6 A Formulation Development Perspective on Critical Interactions Affecting the Performance of Hydrophilic Matrix Tablets
  • 7 In vitro Physical and Imaging Techniques to Evaluate Drug Release Mechanisms from Hydrophilic Matrix Tablets
  • 8 Physiologically-Based Pharmacokinetic Modelling in the Development and Evaluation of Hydrophilic Matrix Tablets
  • 9 Approaches to Rapid In Vivo Optimization of Hydrophilic Matrix Tablets
  • 10 Extrusion: an Enabling Technology for Controlled Release Hydrophilic Matrix Systems
  • 11 Microenvironmental pH Control and Mixed Polymer Approaches to Optimize Drug Delivery with Hydrophilic Matrix Tablets
  • 12 Evolving Biopharmaceutics Perspectives for Hydrophilic Matrix Tablets: Dosage Form-Food Interactions and Dosage Form Gastrointestinal Tract Interactions.
  • 1 Hydrophilic Matrix Dosage Forms: Definitions, General Attributes and the Evolution of Clinical Utilization
  • 2 Design and Evaluation of Hydroxypropyl Methylcellulose Matrix Tablets for Oral Controlled Release: a Historical Perspective
  • 3 An Industrial Perspective on Hydrophilic Matrix Tablets based on Hyproxypropyl Methylcellulose (Hypromellose)
  • 4 Natural Polysaccharides in Hydrophilic Matrices
  • 5 Applications of Polyethylene Oxide (POLYOX) in Hydrophilic Matrices
  • 6 A Formulation Development Perspective on Critical Interactions Affecting the Performance of Hydrophilic Matrix Tablets
  • 7 In vitro Physical and Imaging Techniques to Evaluate Drug Release Mechanisms from Hydrophilic Matrix Tablets
  • 8 Physiologically-Based Pharmacokinetic Modelling in the Development and Evaluation of Hydrophilic Matrix Tablets
  • 9 Approaches to Rapid In Vivo Optimization of Hydrophilic Matrix Tablets
  • 10 Extrusion: an Enabling Technology for Controlled Release Hydrophilic Matrix Systems
  • 11 Microenvironmental pH Control and Mixed Polymer Approaches to Optimize Drug Delivery with Hydrophilic Matrix Tablets
  • 12 Evolving Biopharmaceutics Perspectives for Hydrophilic Matrix Tablets: Dosage Form-Food Interactions and Dosage Form Gastrointestinal Tract Interactions.
Book
1 online resource (xiii, 119 pages) : illustrations.
The book addresses the interdisciplinary scientific approach for the systemic understanding of connections between major human diseases and their treatment regime by applying the tools and techniques of nanotechnology. It also highlights the interdisciplinary collaborative researches for innovation in Biomedical Sciences. The book is a first volume which presents collection of best papers presented in the First International Conference on Infectious Diseases and Nanomedicine held during Dec. 15-18, 2012 in Kathmandu, Nepal. The book focuses mainly on the topics: emerging infectious diseases; antimicrobial agents, vaccines and immunity; drug design, drug delivery and tissue engineering; and nanomaterials and biomedical materials.
The book addresses the interdisciplinary scientific approach for the systemic understanding of connections between major human diseases and their treatment regime by applying the tools and techniques of nanotechnology. It also highlights the interdisciplinary collaborative researches for innovation in Biomedical Sciences. The book is a first volume which presents collection of best papers presented in the First International Conference on Infectious Diseases and Nanomedicine held during Dec. 15-18, 2012 in Kathmandu, Nepal. The book focuses mainly on the topics: emerging infectious diseases; antimicrobial agents, vaccines and immunity; drug design, drug delivery and tissue engineering; and nanomaterials and biomedical materials.
Book
1 online resource (xv, 61 pages) : illustrations (some color).
Book
1 online resource.
Book
xiii, 418 p. : ill. ; 26 cm.
  • A brief history of drug discovery
  • The modern drug process
  • A trip through the body
  • Enzymes as drug targets
  • Receptors as drug targets
  • Oligonucleotides as drug targets
  • Pharmacokinetics
  • Metabolism
  • Molecular structure and diversity
  • Lead discovery
  • Lead optimization : traditional methods
  • Lead optimization : Hansch analysis
  • Aspects in pharmaceutical synthesis.
  • A brief history of drug discovery
  • The modern drug process
  • A trip through the body
  • Enzymes as drug targets
  • Receptors as drug targets
  • Oligonucleotides as drug targets
  • Pharmacokinetics
  • Metabolism
  • Molecular structure and diversity
  • Lead discovery
  • Lead optimization : traditional methods
  • Lead optimization : Hansch analysis
  • Aspects in pharmaceutical synthesis.
Chemistry & ChemEng Library (Swain)
Status of items at Chemistry & ChemEng Library (Swain)
Chemistry & ChemEng Library (Swain) Status
Stacks
RS403 .S745 2014 Unknown
Book
1 online resource.
  • Introduction
  • Lead discovery and lead modification
  • Receptors
  • Enzymes
  • Enzyme inhibition and inactivation
  • Dna-interactive agents
  • Drug resistance and drug synergism
  • Drug metabolism
  • Prodrugs and drug delivery systems.
  • Introduction
  • Lead discovery and lead modification
  • Receptors
  • Enzymes
  • Enzyme inhibition and inactivation
  • Dna-interactive agents
  • Drug resistance and drug synergism
  • Drug metabolism
  • Prodrugs and drug delivery systems.
Book
online resource (xxvii, 1039 pages) : illustrations
Medical Library (Lane)
Status of items at Medical Library (Lane)
Medical Library (Lane) Status
Check Medical Library (Lane) catalog for status
CRCNETBASE Unknown
Book
1 online resource (xxvi, 698 pages)
  • Introduction to biopharmaceuticals
  • Distinctions of biologic versus small molecule platforms in drug development
  • Financing biologic drug development
  • Application of biotechnology in drug discovery and early development
  • Large-scale production of recombinant proteins
  • Clinical pharmacology, toxicology, and therapeutic dosage & response
  • Clinical evaluation and regulatory approval & enforcement of biopharmaceuticals
  • Pharmacoeconomics and drug pricing / Garrison
  • Antibodies and derivatives
  • Hematopoietic growth and coagulation factors
  • Cytokines and interferons
  • Hormones
  • Enzymes
  • Vaccines / Hu, Ho
  • Other biopharmaceutical products
  • Advances in personalized medicine : pharmacogenetics in drug therapy
  • Gene and cell therapy
  • Pharmacoeconomics, outcome, and health technology assessment research in drug development
  • Summary and future prospects.
  • Introduction to biopharmaceuticals
  • Distinctions of biologic versus small molecule platforms in drug development
  • Financing biologic drug development
  • Application of biotechnology in drug discovery and early development
  • Large-scale production of recombinant proteins
  • Clinical pharmacology, toxicology, and therapeutic dosage & response
  • Clinical evaluation and regulatory approval & enforcement of biopharmaceuticals
  • Pharmacoeconomics and drug pricing / Garrison
  • Antibodies and derivatives
  • Hematopoietic growth and coagulation factors
  • Cytokines and interferons
  • Hormones
  • Enzymes
  • Vaccines / Hu, Ho
  • Other biopharmaceutical products
  • Advances in personalized medicine : pharmacogenetics in drug therapy
  • Gene and cell therapy
  • Pharmacoeconomics, outcome, and health technology assessment research in drug development
  • Summary and future prospects.
Book
1 online resource.

Looking for different results?

Modify your search: Search all fields

Search elsewhere: Search WorldCat Search library website